To test this hypothesis, we used F9H4 to capture soluble CD16a shed in supernatants from the leukemia cell line that was engineered to express CD16aWT; F9H4 captured in ELISA plates soluble CD16a shed by this cell line in vitro (Supplementary Fig. 16C). Here, FCGR3A is linked to leukemia.